Reuters logo
BRIEF-Medivir says enrollment completed in the MIV-711 osteoarthritis extension study
June 9, 2017 / 6:40 AM / 4 months ago

BRIEF-Medivir says enrollment completed in the MIV-711 osteoarthritis extension study

June 9 (Reuters) - Medivir AB

* Enrollment completed in the MIV-711 osteoarthritis extension study and data monitoring committee recommendation to “go ahead” Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below